Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Drug-Drug Interaction Study On A Novel Cardiovascular Medication
Learn how Altasciences leveraged its expertise to design, recruit, and conduct complex DDI studies, assessing pharmacokinetic and pharmacodynamic impacts of co-administered drugs.
Reducing Inventory Errors In Clinical Trials
Can a digital double-check save your trial from data errors? How does verifying shipments at receipt slash inventory mistakes? Learn to protect protocol integrity and patient safety.
Retention Through Intention — Designing Truly Patient-Centric Trials
High drop-out rates threaten clinical trial integrity. Implementing decentralized solutions and proactive support strategies during protocol design can significantly improve patient enrollment and retention.
Bringing Intelligence Into The Flow Of Clinical Trials
AI-driven trial intelligence turns complex data into real-time insight, enabling earlier risk detection, stronger oversight, and smarter decisions across the trial lifecycle.

Unique IRT Implementation Considerations For Personalized Medicine Trials
8/22/2025

The rise of personalized and precision medicine is reshaping the clinical trial landscape and, as the number of these specialized trials increases, so does the complexity of managing them effectively.
Recruitment Strategies For Faster Enrollment And Reliable Results
5/14/2025

This presentation highlights recruitment strategies that lead to faster enrollment timelines, optimized budgets, and consistently reliable results.
Accelerating Enrollment And Upholding Quality In Complex Oncology Trials
5/5/2026

Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.
Human Abuse Potential: Study Management
5/1/2026

Learn how human abuse potential studies are strengthened through thoughtful, targeted volunteer selection, clearly defined inclusion and exclusion criteria, and disciplined study oversight.
Direct-To-Patient Strategies Helping CRO Exceed Enrollment Targets
3/6/2026

This deep dive into a successful rescue mission of a Type 1 Diabetes clinical trial reveals how shifting to a direct-to-patient digital strategy can turn a failing timeline into a success story.

Why Central IRBs Matter For Efficient Clinical Trials

“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”

Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC Services

Fast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.
Selecting The Right Pain Model For Early Phase Analgesic Trials

Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.
Elosity: Next-Generation RTSM

With its agile, user-centric approach, Elosity empowers sponsors, sites, and operational teams to manage clinical programs on their terms while meeting the demands of modern clinical research.
Recruitment Strategies: A Behind The Scenes Look

Explore a dynamic recruitment strategy being used to address the growing demand for participants in early-stage clinical trials while overcoming regulatory and ethical challenges.
Biostatistics: End-To-End Management

Discover how a team of biostatistics and pharmacokinetics experts can offer specialized guidance for clinical trial design and analysis.